GlassScriptPhysician profile
Angeline Prabhu
NPI 1245645878
$4,336.14
in general payments reported to CMS, 2019-2025
18 companies · $511 in 2025
The $511 reported for 2025 was more than what a typical Infectious Disease provider received nationally (typical 2025 total: $187).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $124 · 2022: $730 · 2023: $1,677 · 2024: $1,295 · 2025: $511.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,024 · Education: $458.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,024.25 |
| Education | $458.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Viiv Healthcare Company | $1,108.09 | 2022-2025 | Dovato, Cabenuva, Apretude |
| Merck Sharp & Dohme LLC | $776.67 | 2022-2025 | Zerbaxa, Pifeltro, Delstrigo |
| Gilead Sciences, INC. | $654.21 | 2022-2024 | Veklury |
| Astellas Pharma US INC | $498.91 | 2023-2024 | Cresemba |
| Shionogi INC | $203.57 | 2022-2025 | Fetroja |
| Ferring Pharmaceuticals INC. | $181.78 | 2023-2025 | Rebyota |
| La Jolla Pharmaceutical Company | $165.66 | 2022-2025 | Xacduro |
| Paratek Pharmaceuticals, INC. | $127.36 | 2022 | |
| Abbvie INC. | $116.17 | 2022-2025 | |
| Janssen Biotech, INC. | $106.09 | 2022-2023 | Symtuza, Simponi Aria, Tremfya |
| Intuitive Surgical, INC. | $82.04 | 2024 | |
| Insmed, INC. | $60.09 | 2024-2025 | Arikayce |
| Octapharma USA, INC. | $32.47 | 2023 | Octagam Immune Globulin (Human) |
| Organon LLC | $29.18 | 2023 | Hadlima |
| Emd Serono, INC. | $21.65 | 2023 | Serostim |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Napo Pharmaceuticals INC | $16.73 | 2023 | Mytesi |
| Electromed, INC. | $15.78 | 2023 | Smartvest |
| Kci USA, INC. | $15.68 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Angeline Prabhu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.